Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2012
10/16/2012US8287862 Multidrug resistance-associated polypeptide
10/16/2012US8287861 Anti-human interleukin-20 antibodies
10/16/2012US8287860 Immunogen and antivenom against violin spider venom
10/16/2012US8287859 Methods of reducing toxicity and effects of cocaine by administering a butyrylcholinesterase (BChE)-albumin fusion protein
10/16/2012US8287856 PD-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof
10/16/2012US8287855 V. cholerae hyperexpressing recombinant cholera toxin B subunit showing dual immunogenicity
10/16/2012US8287849 Biodegradable poly(beta-amino esters) and uses thereof
10/16/2012CA2634992C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
10/16/2012CA2600195C Combinations for the treatment of cancer
10/16/2012CA2545714C Neutralizing human antibodies to anthrax toxin generated by recall technology
10/16/2012CA2527196C Diagnostic method for atherosclerosis
10/16/2012CA2516028C Conjugates comprising a cancer targeting molecule linked to a liver-expressed chemokine
10/16/2012CA2480696C Peptide epitopes common to antigens of the same multigene family
10/16/2012CA2457804C Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles
10/16/2012CA2455271C Use of musk autoantibodies
10/16/2012CA2451847C A novel engineered superantigen for human therapy
10/16/2012CA2442648C Oncolytic virus therapy
10/16/2012CA2412498C Non-human animal models of tolerance to hepatitis c virus immunogenes
10/16/2012CA2411392C Tetrameric antibody complexes for blocking non-specific binding of antigens
10/16/2012CA2404340C Methods of blocking tissue destruction by autoreactive t cells
10/16/2012CA2368357C Methods for treating congestive heart failure
10/16/2012CA2329829C Protein purification by ion exchange chromatography
10/16/2012CA2132873C Peptides useful for inducing tolerance
10/11/2012WO2012139106A2 Herpes simplex virus
10/11/2012WO2012139099A2 Herpes simplex virus vaccine
10/11/2012WO2012139097A2 Method of inducing neutralizing antibodies to human immunodeficiency virus
10/11/2012WO2012139094A2 Method of developing a vaccine using peptide-poly ic complexes
10/11/2012WO2012139081A2 Methods for treating conditions associated with masp-2 dependent complement activation
10/11/2012WO2012139069A2 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
10/11/2012WO2012138975A1 Anti-fgfr4 antibodies and methods of use
10/11/2012WO2012138958A1 Formulations with reduced viscosity
10/11/2012WO2012138911A2 Conjugates of anti-hiv drugs and somatostatin analogs
10/11/2012WO2012138880A2 Methods of treating inflammatory diseases by targeting the chemoattractant cytokine receptor 2 (ccr2) or chemokine (c-c motif) ligand 2 (ccl2)
10/11/2012WO2012138836A2 Attenuated live vaccines for aquatic animals
10/11/2012WO2012138774A2 Methods of improving vaccine immunogenicity
10/11/2012WO2012138768A2 Anti-cd154 antibodies having impaired fcr binding and/or complement binding properties and the use thereof in immune therapies
10/11/2012WO2012138754A2 Mycobacterial vaccine vectors and methods of using the same
10/11/2012WO2012138575A1 Compositions and methods for increasing muscle function and mass
10/11/2012WO2012138570A2 Modulating bacterial mam polypeptides in pathogenic disease
10/11/2012WO2012138537A1 Compositions and methods for treatment of ovarian, peritoneal, and fallopian tube cancer
10/11/2012WO2012138377A2 The use of listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals
10/11/2012WO2012138102A2 Dlk1-specific human antibodies and pharmaceutical composition containing same
10/11/2012WO2012138100A2 Activin receptor type ii b inhibitors comprising dlk1 extracellular water-soluble domain
10/11/2012WO2012137993A1 Antibodies against angiopoietins 1 and 2, and their use
10/11/2012WO2012137683A1 Recombinant polypeptide production method
10/11/2012WO2012137538A1 Cytotoxic t cell inducing composition
10/11/2012WO2012137479A1 Peptide which can induce antibody capable of recognizing stereostructure of hiv
10/11/2012WO2012137072A1 Therapeutic vaccine compositions inducing tolerance to hiv for treating hiv infections in humans
10/11/2012WO2012137071A2 Pharmaceutical compositions for preventing and/or treating an hiv disease in humans
10/11/2012WO2012136831A1 Non-replicative virions of human immunodeficiency virus and therapeutic applications thereof
10/11/2012WO2012136824A1 Non-self t - cell epitope fused to an antibody that recognises a tumour - specific cell -surface receptor and uses thereof.
10/11/2012WO2012136823A1 Process for producing an immunogenic composition containing tetanus toxoid
10/11/2012WO2012136790A1 Compositions comprising fusion proteins or conjugates with an improved half -life
10/11/2012WO2012136739A1 Method for treating ifnalpha related conditions
10/11/2012WO2012136653A1 Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
10/11/2012WO2012136534A2 Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
10/11/2012WO2012136519A1 Use of neutralizing prolactin receptor antibodies for the treatment and prevention of antiestrogen-resistant breast cancer
10/11/2012WO2012136172A1 Method for producing injectable formulations of blood-derived protein materials, and materials obtained using said method
10/11/2012WO2012135959A1 Protease cleavage site peptides as an hiv vaccine
10/11/2012WO2012110489A3 Novel european prrsv strain
10/11/2012WO2012106497A3 Selection and treatment of subjects
10/11/2012WO2012097185A3 Omv vaccine against burkholderia infections
10/11/2012WO2012088302A3 Half immunoglobulin binding proteins and uses thereof
10/11/2012WO2012085936A3 Recombinant respiratory syncytial virus plasmids and vaccines
10/11/2012WO2012085603A3 Dna sensors
10/11/2012WO2012073257A3 Vaccine formulation for prophylaxis and treatment of chandipura virus infections in mammals
10/11/2012WO2011104381A3 Stable antibody containing compositions
10/11/2012US20120259267 Chemically Amplified Response Strategies for Medical Sciences
10/11/2012US20120259151 Pyridopyrazine derivatives and their use
10/11/2012US20120259095 Monoclonal antibodies with enhanced adcc function
10/11/2012US20120258872 Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
10/11/2012US20120258149 Methods and Compositions for the Prevention and Treatment of Influenza
10/11/2012US20120258146 Method of treating organic diseases of nervous system, pschoorganic syndrome and encephalopathy
10/11/2012US20120258145 Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof
10/11/2012US20120258142 Glycolipids and analogues thereof as antigens for nkt cells
10/11/2012US20120258140 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
10/11/2012US20120258139 Attenuated Live Vaccines for Aquatic Animals
10/11/2012US20120258137 Immunogenic compositions comprising nanoemulsion and hepatitis b virus immunogen and methods of using the same
10/11/2012US20120258136 Methods for cultivating cells, propagating and purifying viruses
10/11/2012US20120258135 Immunogenic anti-inflammatory compositions
10/11/2012US20120258134 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
10/11/2012US20120258132 Vagal Nerve-Based Disorders
10/11/2012US20120258130 Vaccination regimen for b-cell vaccines
10/11/2012US20120258129 Mycobacterium tuberculosis fusion protein and uses thereof
10/11/2012US20120258128 Infection Factor Assay
10/11/2012US20120258127 Vaccine peptides
10/11/2012US20120258126 Molecular Vaccines for Infectious Disease
10/11/2012US20120258125 Method to identify a novel class of immunologic adjuvants
10/11/2012US20120258124 Antigen-antibody complexes as hiv-1 vaccines
10/11/2012US20120258123 Biomarkers for sensitive detection of statin-induced muscle toxicity
10/11/2012US20120258122 Antibodies Directed to Angiopoietin-1 and Angiopoietin-2 and Uses Thereof
10/11/2012US20120258121 Generation of anti-fn14 monoclonal antibodies by ex-vivo accelerated antibody evolution
10/11/2012US20120258120 Compositions and methods for the systemic treatment of arthritis
10/11/2012US20120258119 Anti-fibroblast activation protein antibodies and methods and uses thereof
10/11/2012US20120258118 Antibody therapeutics with local activity in the digestive tract
10/11/2012US20120258117 Methods and compositions for modulation of histone ubiquitination
10/11/2012US20120258116 Method for inducing cancer cell apoptosis or inhibiting the cancer cell migration
10/11/2012US20120258115 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
10/11/2012US20120258114 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
10/11/2012US20120258113 Susbstantially pure steroidogenesis inducing peptide and uses thereof
1 ... 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 ... 1823